Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
Selvester QRS score
aortic stenosis
mortality
myocardial fibrosis
transaortic valve replacement
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
18
11
2019
revised:
28
03
2020
accepted:
31
03
2020
pubmed:
18
4
2020
medline:
25
9
2021
entrez:
18
4
2020
Statut:
ppublish
Résumé
Few data exist regarding the late clinical impact of the Selvester score prediction of myocardial fibrosis after transcatheter aortic valve replacement (TAVR). This study evaluated the predictive power of the Selvester score on survival in patients with aortic stenosis (AS) undergoing TAVR. Patients with severe AS who had preoperative electrocardiograms were included. Clinical follow-up was obtained retrospectively. The primary endpoint was all-cause mortality. Secondary endpoints were cardiovascular death and major adverse cardiac events (MACEs). Two-hundred twenty-eight patients were included (mean age, 81.5 ± 7.4 years; women, 58.3%). Deceased patients had a higher mean score (4.6 ± 3.2 vs. 1.4 ± 1.3; p < .001). At a mean follow-up of 36.2 ± 21.2 months, the Selvester score was independently associated with all-cause mortality (hazard ratio [HR], 1.65; 95% confidence interval [CI], 1.48-1.84; p < .001), cardiovascular death (HR, 1.59; 95% CI, 1.38-1.74; p < .001), and MACE (HR, 1.55; 95% CI, 1.30-1.68; p < .001). After 5 years, the mortality risk was incrementally related to the Selvester score. The involvement of the inferior wall of the left ventricle was a lower mortality risk factor (HR, 0.42; 95% CI, 0.18-0.98; p = .046). For a Selvester score of 3, the area under the curve showed 0.92, 0.94, and 0.86 (p < .001), respectively, for 1, 2, and 3 years. Elevated Selvester scores increase the risk of poor outcomes in patients with AS undergoing TAVR. The involvement of the anterior or lateral wall presents worse prognosis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E95-E103Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111:3316-3326.
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-1620.
Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105:146-152.
Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2017;69:1313-1346.
Sinning JM, Wollert KC, Sedaghat A, et al. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J. 2015;170:821-829.
Green P, Arnold SV, Cohen DJ, et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol. 2015;116:264-269.
Kodali S, Williams MR, Doshi D, et al. Sex-specific differences at presentation and outcomes among patients undergoing transcatheter aortic valve replacement -a cohort study. Ann Intern Med. 2016;164:377-384.
Barone-Rochette G, Piérard S, De Meester de Ravenstein C, et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014;64:144-154.
Piccirillo G, Moscucci F, Mastropietri F, et al. Possible predictive role of electrical risk score on transcatheter aortic valve replacement outcomes in older patients: preliminary data. Clin Interv Aging. 2018;13:1657-1667.
Selvester RH, Wagner JO, Rubin HB. Quantitation of myocardial infarct size and location by electrocardiogram and vectorcardiogram. Quant Cardiol. 1972;8:31-44.
Chaudhry U, Platonov PG, Jablonowski R, et al. Evaluation of the ECG based Selvester scoring method to estimate myocardial scar burden and predict clinical outcome in patients with left bundle branch block, with comparison to late gadolinium enhancement CMR imaging. Ann Noninvasive Electrocardiol. 2017;22(5):e12440.
Jaarsma C, Bekkers SC, Haidari Z, et al. Comparison of different electrocardiographic scoring systems for detection of any previous myocardial infarction as assessed with cardiovascular magnetic resonance imaging. Am J Cardiol. 2013;112(8):1069-1074.
Roubin GS, Shen WF, Kelly DT, Harris PJ. The QRS scoring system for estimating myocardial infarct size: clinical, angiographic and prognostic correlations. J Am Coll Cardiol. 1983;2:38-44.
Bounous EP Jr, Califf RM, Harrell FE Jr, et al. Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. J Am Coll Cardiol. 1988;11:35-41.
Fioretti P, Tijssen JG, Azar AJ, et al. Prognostic value of predischarge 12 lead electrocardiogram after myocardial infarction compared with other routine clinical variables. Br Heart J. 1987;57:306-312.
Richardson K, Engel G, Yamazaki T, Chun S, Froelicher VF. Electrocardiographic damage scores and cardiovascular mortality. Am Heart J. 2005;149:458-463.
Hannink LG, Wagner GS, Kisslo J, et al. Influence of QRS infarct score and QRS duration prior to transcatheter aortic valve replacement on follow-up left ventricular end systolic volume in patients with new persistent left bundle branch block. J Electrocardiol. 2015;48:637-642.
Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2012;9:15-29.
Kappetein AP, Head SJ, Généreux P, et al. Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33:2403-2418b.
Loring Z, Chelliah S, Selvester RH, Wagner G, Strauss DG. A detailed guide for quantification of myocardial scar with the Selvester QRS score in the presence of electrocardiogram confounders. J Electrocardiol. 2011;44:544-554.
Vahanian A, Alfieri O, Andreotti F, et al. Joint task force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1-S44.
D'Ascenzo F, Gonella A, Moretti C, et al. Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention. 2013;9(3):367-372.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706-1715.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.
Nombela-Franco L, Eltchaninoff H, Zahn R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015;101:1395-1405.
Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5:974-981.
Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
Barbanti M, Webb JG, Hahn RT, et al. Placement of Aortic Transcatheter Valve Trial Investigators. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013;128:2776-2784.
Azevedo CF, Nigri M, Higuchi ML, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56:278-287.
Bignoto TC, Moreira DAR, Habib RG, et al. Electrocardiography scar quantification correlates with scar size of hypertrophic cardiomyopathy seen by multidetector computed tomography. Clin Cardiol. 2018;41:837-842.
Strauss DG, Cardoso S, Lima JA, Rochite CE, Wu KC. ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease. Heart. 2011;97:357-361.
Rosengarten JA, Scott PA, Chiu OKH, Shambrook JS, Curzen NP, Morgan JM. Can QRS scoring predict left ventricular scar and clinical outcomes? Europace. 2013;15:1034-1041.
Strauss DG, Selvester RH, Lima JA, et al. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects correlation with cardiac magnetic resonance and arrhythmogenesis. Circ Arrhythm Electrophysiol. 2008;1:327-336.
Kraaier K, van Dessel PFHM, van der Palen J, Wilde AAM, Scholten MF. ECG quantification of myocardial scar does not differ between primary and secondary prevention icd recipients with ischemic heart disease. PACE. 2010;33:192-197.
Wieslander B, Atwater BD, Wagner GS, Ugander M. Selvester QRS scoring in conduction abnormalities: caution recommended due to recent findings. J Electrocardiol. 2015;48:777-778.
Wieslander B, Nijveldt R, Klem I, et al. Evaluation of Selvester QRS score for use in presence of conduction abnormalities in a broad population. Am Heart J. 2015;170:346-352.
Yan AT, Koh M, Chan KK, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART Aortic Stenosis Study. J Am Coll Cardiol. 2017;69:1523-1532.
Zhao Y, Nicoll R, He YH, Henein MY. The effect of statins on valve function and calcification in aortic stenosis: a meta-analysis. Atherosclerosis. 2016;246:318-324.
Huded CP, Benck LR, Stone NJ, et al. Relation of intensity of statin therapy and outcomes after transcatheter aortic valve replacement. Am J Cardiol. 2017;119:1832-1838.
Lluberas S, Abizaid A, Siqueira D, et al. Initial experience of two national centers in transcatheter aortic prosthesis implantation. Arq Bras Cardiol. 2014;102(4):336-344.
O'Sullivan CJ, Wenaweser P, Ceylan O, et al. Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv. 2015;8(7):e002358.
Stone PH, Raabe DS, Jaffe AS, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol. 1988;11:453-463.
Nienhuis MB, Ottervanger JP, Dambrink JH, et al. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction. Coron Artery Dis. 2009;20:9-14.